CN106190937A - 一种构建重组大肠杆菌生物合成2’‑岩藻乳糖的方法 - Google Patents
一种构建重组大肠杆菌生物合成2’‑岩藻乳糖的方法 Download PDFInfo
- Publication number
- CN106190937A CN106190937A CN201610562080.9A CN201610562080A CN106190937A CN 106190937 A CN106190937 A CN 106190937A CN 201610562080 A CN201610562080 A CN 201610562080A CN 106190937 A CN106190937 A CN 106190937A
- Authority
- CN
- China
- Prior art keywords
- gene
- lactose
- plasmid
- rock algae
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims abstract description 56
- 239000008101 lactose Substances 0.000 title claims abstract description 56
- 239000011435 rock Substances 0.000 title claims abstract description 48
- 241000195493 Cryptophyta Species 0.000 title claims abstract description 47
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 40
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000006798 recombination Effects 0.000 title claims abstract description 18
- 238000005215 recombination Methods 0.000 title claims abstract description 18
- 239000013612 plasmid Substances 0.000 claims abstract description 52
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 32
- 230000008859 change Effects 0.000 claims abstract description 7
- 238000003209 gene knockout Methods 0.000 claims abstract description 7
- 238000010353 genetic engineering Methods 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 59
- 239000001963 growth medium Substances 0.000 claims description 26
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 24
- 239000012634 fragment Substances 0.000 claims description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 17
- 108090000992 Transferases Proteins 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 14
- LQEBEXMHBLQMDB-JGQUBWHWSA-N GDP-beta-L-fucose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=C(C(NC(N)=N3)=O)N=C2)O1 LQEBEXMHBLQMDB-JGQUBWHWSA-N 0.000 claims description 14
- 230000008034 disappearance Effects 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- LQEBEXMHBLQMDB-UHFFFAOYSA-N GDP-L-fucose Natural products OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C3=C(C(N=C(N)N3)=O)N=C2)O1 LQEBEXMHBLQMDB-UHFFFAOYSA-N 0.000 claims description 13
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 13
- 229960005322 streptomycin Drugs 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 229960000723 ampicillin Drugs 0.000 claims description 12
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 12
- -1 beta galactose glycosides Chemical class 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 229940041514 candida albicans extract Drugs 0.000 claims description 10
- 239000012138 yeast extract Substances 0.000 claims description 10
- 102000004357 Transferases Human genes 0.000 claims description 9
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 9
- 108010089934 carbohydrase Proteins 0.000 claims description 8
- 230000037353 metabolic pathway Effects 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 229930182470 glycoside Natural products 0.000 claims description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 claims description 6
- 108090000301 Membrane transport proteins Proteins 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 229930027917 kanamycin Natural products 0.000 claims description 6
- 229960000318 kanamycin Drugs 0.000 claims description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 6
- 229930182823 kanamycin A Natural products 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000012137 tryptone Substances 0.000 claims description 6
- 230000003827 upregulation Effects 0.000 claims description 6
- 101100075927 Aspergillus aculeatus mndA gene Proteins 0.000 claims description 5
- 101100022282 Escherichia coli O157:H7 manC2 gene Proteins 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 claims description 5
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 5
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 101150088678 manB gene Proteins 0.000 claims description 5
- 101150032120 manC gene Proteins 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 101150117960 rcsA gene Proteins 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 210000002706 plastid Anatomy 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000007836 KH2PO4 Substances 0.000 claims description 2
- MNMDQPHROBCYHZ-UHFFFAOYSA-L [Na+].[Na+].O.[PH2](=O)[O-].[PH2](=O)[O-] Chemical compound [Na+].[Na+].O.[PH2](=O)[O-].[PH2](=O)[O-] MNMDQPHROBCYHZ-UHFFFAOYSA-L 0.000 claims description 2
- 235000019270 ammonium chloride Nutrition 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 229910052564 epsomite Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000012549 training Methods 0.000 claims description 2
- 241000228143 Penicillium Species 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 16
- 238000011953 bioanalysis Methods 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 230000004888 barrier function Effects 0.000 abstract 1
- 230000029087 digestion Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 229920001542 oligosaccharide Polymers 0.000 description 7
- 150000002482 oligosaccharides Chemical class 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- 235000020256 human milk Nutrition 0.000 description 6
- 210000004251 human milk Anatomy 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- 102000012410 DNA Ligases Human genes 0.000 description 5
- 108010061982 DNA Ligases Proteins 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229940097572 chloromycetin Drugs 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 241000590002 Helicobacter pylori Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 101150041441 fcl gene Proteins 0.000 description 4
- 229940037467 helicobacter pylori Drugs 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101100048435 Caenorhabditis elegans unc-18 gene Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 101150066555 lacZ gene Proteins 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 2
- 108010062427 GDP-mannose 4,6-dehydratase Proteins 0.000 description 2
- 102000002312 GDPmannose 4,6-dehydratase Human genes 0.000 description 2
- 101150043276 Lon gene Proteins 0.000 description 2
- 102000048193 Mannose-6-phosphate isomerases Human genes 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- MVMSCBBUIHUTGJ-UHFFFAOYSA-N 10108-97-1 Natural products C1=2NC(N)=NC(=O)C=2N=CN1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O MVMSCBBUIHUTGJ-UHFFFAOYSA-N 0.000 description 1
- 101150028074 2 gene Proteins 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010037637 E coli beta-galactoside permease Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101100001670 Emericella variicolor andE gene Proteins 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- MVMSCBBUIHUTGJ-GDJBGNAASA-N GDP-alpha-D-mannose Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=C(NC(=O)C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O MVMSCBBUIHUTGJ-GDJBGNAASA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 101710136501 Mannan endo-1,4-beta-mannosidase Proteins 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 101150106565 gmd gene Proteins 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 229930193965 lacto-N-fucopentaose Natural products 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 101150039322 outE gene Proteins 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01271—GDP-L-fucose synthase (1.1.1.271)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01069—Galactoside 2-alpha-L-fucosyltransferase (2.4.1.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/02—Pentosyltransferases (2.4.2)
- C12Y204/02008—Hypoxanthine phosphoribosyltransferase (2.4.2.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01047—GDP-mannose 4,6-dehydratase (4.2.1.47), i.e. GMD
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01008—Mannose-6-phosphate isomerase (5.3.1.8)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562080.9A CN106190937B9 (zh) | 2016-07-18 | 2016-07-18 | 一种构建重组大肠杆菌生物合成2’-岩藻乳糖的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562080.9A CN106190937B9 (zh) | 2016-07-18 | 2016-07-18 | 一种构建重组大肠杆菌生物合成2’-岩藻乳糖的方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
CN106190937A true CN106190937A (zh) | 2016-12-07 |
CN106190937B CN106190937B (zh) | 2019-05-14 |
CN106190937B9 CN106190937B9 (zh) | 2020-12-01 |
Family
ID=57475613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610562080.9A Active CN106190937B9 (zh) | 2016-07-18 | 2016-07-18 | 一种构建重组大肠杆菌生物合成2’-岩藻乳糖的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106190937B9 (zh) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109609422A (zh) * | 2018-11-20 | 2019-04-12 | 安徽天凯生物科技有限公司 | 一种可以产2’-岩藻基乳糖菌株的构建方法 |
CN109735479A (zh) * | 2019-01-30 | 2019-05-10 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
CN110172486A (zh) * | 2019-05-14 | 2019-08-27 | 天津科技大学 | 一种合成2’-岩藻糖基乳糖的方法 |
CN110592162A (zh) * | 2019-08-15 | 2019-12-20 | 安徽天凯生物科技有限公司 | 一种产2’-岩藻基乳糖菌株最佳发酵条件的构建方法 |
CN110662842A (zh) * | 2017-04-21 | 2020-01-07 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3’-岩藻糖基乳糖的生产方法 |
CN111218488A (zh) * | 2020-02-10 | 2020-06-02 | 中国科学院上海高等研究院 | 一种利用大肠杆菌生产2’-岩藻糖基乳糖的方法 |
CN111471637A (zh) * | 2020-05-08 | 2020-07-31 | 江苏华燕集团有限公司 | 2`-岩藻糖基乳糖高产菌株及其制备方法和用途 |
CN111575220A (zh) * | 2020-05-25 | 2020-08-25 | 江南大学 | 合成2’-岩藻糖基乳糖的重组大肠杆菌及其构建方法与应用 |
CN112029790A (zh) * | 2020-09-10 | 2020-12-04 | 苏州一兮生物科技有限公司 | 一种可合成2’-fl载体及其应用 |
CN112342176A (zh) * | 2020-10-15 | 2021-02-09 | 江南大学 | 产2’-岩藻糖基乳糖的基因工程菌及其应用 |
CN112458034A (zh) * | 2020-12-08 | 2021-03-09 | 南开大学 | 一种基因工程构建的重组大肠杆菌及生物合成6’-唾液乳糖的方法 |
CN112501095A (zh) * | 2020-12-08 | 2021-03-16 | 南开大学 | 一种合成3-岩藻乳糖的重组大肠杆菌构建方法及其应用 |
CN112574936A (zh) * | 2020-12-21 | 2021-03-30 | 中国科学院合肥物质科学研究院 | 一种重组大肠杆菌及其构建方法与应用 |
CN112625990A (zh) * | 2020-12-29 | 2021-04-09 | 量子高科(广东)生物有限公司 | 一种合成2`-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112625987A (zh) * | 2020-12-21 | 2021-04-09 | 南通励成生物工程有限公司 | 一种同时生产2`-岩藻糖基乳糖和d-阿洛酮糖的方法 |
CN112662715A (zh) * | 2021-01-27 | 2021-04-16 | 南开大学 | 一种2’-岩藻糖基乳糖的分批发酵方法 |
CN112662604A (zh) * | 2020-12-29 | 2021-04-16 | 量子高科(广东)生物有限公司 | 一种合成3-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112920234A (zh) * | 2021-01-27 | 2021-06-08 | 南开大学 | 一种2`-岩藻糖基乳糖的富集纯化方法 |
CN113025548A (zh) * | 2021-04-08 | 2021-06-25 | 西南大学 | 基于kosakonia sp.菌株生产2’-岩藻糖基乳糖的重组菌及其方法和应用 |
CN113462629A (zh) * | 2021-07-20 | 2021-10-01 | 南通励成生物工程有限公司 | 一种提高大肠杆菌工程菌合成2’-岩藻糖基乳糖产量的方法 |
CN113832092A (zh) * | 2021-10-20 | 2021-12-24 | 江南大学 | 一种提高乳酰-n-岩藻五糖产量的基因工程菌及其生产方法 |
CN116948928A (zh) * | 2023-06-02 | 2023-10-27 | 虹摹生物科技(上海)有限公司 | 种子培养基及无抗生素、无iptg诱导剂的2’-岩藻糖基乳糖的发酵生产方法 |
WO2023216685A1 (zh) * | 2022-05-10 | 2023-11-16 | 南通励成生物工程有限公司 | 一种以葡萄糖为碳源合成2'-岩藻糖基乳糖的菌株及其构建方法和应用 |
CN118064342A (zh) * | 2024-03-08 | 2024-05-24 | 天益健康科学研究院(镇江)有限公司 | 一种以葡萄糖为碳源合成2′-岩藻糖基乳糖的基因工程菌及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102459605A (zh) * | 2009-06-08 | 2012-05-16 | 詹尼温生物技术有限责任公司 | Hmo合成 |
CN103328630A (zh) * | 2011-01-20 | 2013-09-25 | 詹尼温生物技术有限责任公司 | 新型岩藻糖基转移酶及其应用 |
WO2015175801A1 (en) * | 2014-05-15 | 2015-11-19 | Glycosyn LLC | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides |
-
2016
- 2016-07-18 CN CN201610562080.9A patent/CN106190937B9/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102459605A (zh) * | 2009-06-08 | 2012-05-16 | 詹尼温生物技术有限责任公司 | Hmo合成 |
CN103328630A (zh) * | 2011-01-20 | 2013-09-25 | 詹尼温生物技术有限责任公司 | 新型岩藻糖基转移酶及其应用 |
WO2015175801A1 (en) * | 2014-05-15 | 2015-11-19 | Glycosyn LLC | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides |
Non-Patent Citations (1)
Title |
---|
WON-HEONG LEE等: "Whole cell biosynthesis of a functional oligosaccharide, 20-fucosyllactose, using engineered Escherichia coli", 《MICROBIAL CELL FACTORIES》 * |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110662842A (zh) * | 2017-04-21 | 2020-01-07 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3’-岩藻糖基乳糖的生产方法 |
CN110662842B (zh) * | 2017-04-21 | 2023-03-21 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3-岩藻糖基乳糖的生产方法 |
CN109609422A (zh) * | 2018-11-20 | 2019-04-12 | 安徽天凯生物科技有限公司 | 一种可以产2’-岩藻基乳糖菌株的构建方法 |
CN109735479B (zh) * | 2019-01-30 | 2022-04-01 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
CN109735479A (zh) * | 2019-01-30 | 2019-05-10 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
CN110172486A (zh) * | 2019-05-14 | 2019-08-27 | 天津科技大学 | 一种合成2’-岩藻糖基乳糖的方法 |
CN110592162A (zh) * | 2019-08-15 | 2019-12-20 | 安徽天凯生物科技有限公司 | 一种产2’-岩藻基乳糖菌株最佳发酵条件的构建方法 |
CN111218488A (zh) * | 2020-02-10 | 2020-06-02 | 中国科学院上海高等研究院 | 一种利用大肠杆菌生产2’-岩藻糖基乳糖的方法 |
CN111218488B (zh) * | 2020-02-10 | 2022-11-15 | 中国科学院上海高等研究院 | 一种利用大肠杆菌生产2’-岩藻糖基乳糖的方法 |
CN111471637A (zh) * | 2020-05-08 | 2020-07-31 | 江苏华燕集团有限公司 | 2`-岩藻糖基乳糖高产菌株及其制备方法和用途 |
CN111575220A (zh) * | 2020-05-25 | 2020-08-25 | 江南大学 | 合成2’-岩藻糖基乳糖的重组大肠杆菌及其构建方法与应用 |
CN111575220B (zh) * | 2020-05-25 | 2023-06-02 | 江南大学 | 合成2’-岩藻糖基乳糖的重组大肠杆菌及其构建方法与应用 |
CN112029790A (zh) * | 2020-09-10 | 2020-12-04 | 苏州一兮生物科技有限公司 | 一种可合成2’-fl载体及其应用 |
CN112342176A (zh) * | 2020-10-15 | 2021-02-09 | 江南大学 | 产2’-岩藻糖基乳糖的基因工程菌及其应用 |
CN112458034A (zh) * | 2020-12-08 | 2021-03-09 | 南开大学 | 一种基因工程构建的重组大肠杆菌及生物合成6’-唾液乳糖的方法 |
CN112501095B (zh) * | 2020-12-08 | 2023-05-26 | 南开大学 | 一种合成3-岩藻乳糖的重组大肠杆菌构建方法及其应用 |
CN112458034B (zh) * | 2020-12-08 | 2023-01-24 | 南开大学 | 一种基因工程构建的重组大肠杆菌及生物合成6’-唾液乳糖的方法 |
CN112501095A (zh) * | 2020-12-08 | 2021-03-16 | 南开大学 | 一种合成3-岩藻乳糖的重组大肠杆菌构建方法及其应用 |
CN112625987A (zh) * | 2020-12-21 | 2021-04-09 | 南通励成生物工程有限公司 | 一种同时生产2`-岩藻糖基乳糖和d-阿洛酮糖的方法 |
CN112574936A (zh) * | 2020-12-21 | 2021-03-30 | 中国科学院合肥物质科学研究院 | 一种重组大肠杆菌及其构建方法与应用 |
CN112625987B (zh) * | 2020-12-21 | 2023-01-06 | 南通励成生物工程有限公司 | 一种同时生产2`-岩藻糖基乳糖和d-阿洛酮糖的方法 |
CN112662604A (zh) * | 2020-12-29 | 2021-04-16 | 量子高科(广东)生物有限公司 | 一种合成3-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112662604B (zh) * | 2020-12-29 | 2023-10-20 | 量子高科(广东)生物有限公司 | 一种合成3-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112625990B (zh) * | 2020-12-29 | 2023-06-16 | 量子高科(广东)生物有限公司 | 一种合成2`-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112625990A (zh) * | 2020-12-29 | 2021-04-09 | 量子高科(广东)生物有限公司 | 一种合成2`-岩藻糖基乳糖的重组大肠杆菌及其构建方法 |
CN112920234A (zh) * | 2021-01-27 | 2021-06-08 | 南开大学 | 一种2`-岩藻糖基乳糖的富集纯化方法 |
CN112662715A (zh) * | 2021-01-27 | 2021-04-16 | 南开大学 | 一种2’-岩藻糖基乳糖的分批发酵方法 |
CN113025548A (zh) * | 2021-04-08 | 2021-06-25 | 西南大学 | 基于kosakonia sp.菌株生产2’-岩藻糖基乳糖的重组菌及其方法和应用 |
CN113462629B (zh) * | 2021-07-20 | 2023-01-10 | 南通励成生物工程有限公司 | 一种提高大肠杆菌工程菌合成2’-岩藻糖基乳糖产量的方法 |
CN113462629A (zh) * | 2021-07-20 | 2021-10-01 | 南通励成生物工程有限公司 | 一种提高大肠杆菌工程菌合成2’-岩藻糖基乳糖产量的方法 |
CN113832092B (zh) * | 2021-10-20 | 2023-10-03 | 江南大学 | 一种提高乳酰-n-岩藻五糖产量的基因工程菌及其生产方法 |
CN113832092A (zh) * | 2021-10-20 | 2021-12-24 | 江南大学 | 一种提高乳酰-n-岩藻五糖产量的基因工程菌及其生产方法 |
WO2023216685A1 (zh) * | 2022-05-10 | 2023-11-16 | 南通励成生物工程有限公司 | 一种以葡萄糖为碳源合成2'-岩藻糖基乳糖的菌株及其构建方法和应用 |
CN116948928A (zh) * | 2023-06-02 | 2023-10-27 | 虹摹生物科技(上海)有限公司 | 种子培养基及无抗生素、无iptg诱导剂的2’-岩藻糖基乳糖的发酵生产方法 |
CN118064342A (zh) * | 2024-03-08 | 2024-05-24 | 天益健康科学研究院(镇江)有限公司 | 一种以葡萄糖为碳源合成2′-岩藻糖基乳糖的基因工程菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106190937B (zh) | 2019-05-14 |
CN106190937B9 (zh) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106190937B (zh) | 一种构建重组大肠杆菌生物合成2"-岩藻乳糖的方法 | |
CN106190938B (zh) | 一种构建的重组大肠杆菌及生物合成3’-唾液乳糖的方法 | |
CN113652385B (zh) | 一种高产乳酰-n-四糖的微生物的构建方法及应用 | |
CN112795582B (zh) | 一种适合在微生物中高效合成nad衍生物的酶基因 | |
CN112501095B (zh) | 一种合成3-岩藻乳糖的重组大肠杆菌构建方法及其应用 | |
CN102559769A (zh) | 一种制备异戊二烯的重组细胞及其制备方法 | |
CN113684164A (zh) | 一种高产乳酰-n-新四糖的微生物的构建方法及应用 | |
CN104232595A (zh) | 鞘氨醇单胞菌的虾青素合成酶及其编码基因和鞘氨醇单胞菌遗传操作的方法 | |
CN107916283A (zh) | 一种烟酰胺的生产工艺 | |
CN116478878A (zh) | 一种高产核黄素的枯草芽孢杆菌及其应用 | |
CN110029118A (zh) | 一种合成槲皮素-4’-葡萄糖苷的方法 | |
CN109897862A (zh) | 庆大霉素b生产菌及其制备方法和应用 | |
CN107881140A (zh) | 一株高产甘露醇的肠膜明串珠菌突变菌株及其应用方法 | |
CN113832092A (zh) | 一种提高乳酰-n-岩藻五糖产量的基因工程菌及其生产方法 | |
CN105602876A (zh) | 一种联产Surfactin和Plipastatin的枯草芽孢杆菌菌株及其构建方法 | |
CN103834605B (zh) | 一种阿维菌素产生菌及其制备方法和应用 | |
CN102703495A (zh) | 提高链霉菌抗生素产量的方法及其质粒 | |
CN110343654A (zh) | 一种产蔗糖磷酸化酶的基因工程菌 | |
CN107460152A (zh) | 产红景天苷及其类似物的重组菌、构建方法及用途 | |
ES2443099T3 (es) | Cepa de Escherichia capaz de convertir el XMP en GMP y de mantener el estado inactivado del gen o de los genes asociados a la degradación del GMP y procedimientos para utilizarla | |
CN102719388A (zh) | 提高链霉菌抗生素产量的方法及其质粒 | |
CN109321508A (zh) | 产heparosan的基因工程菌及其应用 | |
CN116004489A (zh) | 一种生产nmn的重组大肠杆菌及其应用 | |
CN108949784A (zh) | 芽孢形成相关基因sigmaF在产酶中的应用 | |
CN107828809A (zh) | 寡褐藻胶裂解酶OalC6的制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CI03 | Correction of invention patent | ||
CI03 | Correction of invention patent |
Correction item: Denomination of Invention|Description Correct: A method of constructing recombinant Escherichia coli for biosynthesis of 2 '- fucose False: A method for the biosynthesis of 2 "- fucoidose by recombinant Escherichia coli Number: 20-01 Page: full text Volume: 35 Correction item: Denomination of Invention Correct: A method of constructing recombinant Escherichia coli for biosynthesis of 2 '- fucose False: A method for the biosynthesis of 2 "- fucoidose by recombinant Escherichia coli Number: 20-01 Volume: 35 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240320 Address after: 300074 Tianjin City, Nankai District Wei Jin Road No. 94 Patentee after: NANKAI University Country or region after: China Patentee after: Tianjin Nankai University Asset Management Co.,Ltd. Address before: No. 23 Hongda Street, Economic and Technological Development Zone, Tanggu District, Tianjin City, 300457 Patentee before: NANKAI University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240407 Address after: Room 1201-1, Building 6, Artificial Intelligence Building, No. 17 Yesheng Road, Economic and Technological Development Zone, Xiqing District, Tianjin, 300385 Patentee after: Tianjin Hesheng Biotechnology Co.,Ltd. Country or region after: China Address before: 300074 Tianjin City, Nankai District Wei Jin Road No. 94 Patentee before: NANKAI University Country or region before: China Patentee before: Tianjin Nankai University Asset Management Co.,Ltd. |